HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tartter, P. I. Articles by Kirschner, P. Search for Related Content PubMed PubMed Citation Articles by Tartter, P. I. Articles by Kirschner, P.

The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 659-662, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer

PI Tartter, L Burrows and P Kirschner

Recent studies suggest that pretransplant blood transfusions prolong kidney graft survival by nonspecific immune suppression. Since immune suppression in patients with cancer is associated with early recurrence and poor prognosis, we studied the relationship of perioperative blood transfusion to recurrence of Stage I (subset N0) lung cancer. Technique- related variables were minimized by limiting the study to one surgeon (P. A. K.). Life-table and Cox proportional hazards analysis of age, sex, tumor size, histopathology, admission and discharge hematocrit values, estimated operative blood loss, duration of operation, extent of resection, anesthetic agents, and blood transfusion revealed two statistically significant prognostic factors: extent of resection (p = 0.0056) and use or non-use of transfusions (p = 0.0283). The cumulative 5 year disease-free survival rate of the 15 patients undergoing pneumonectomy was 42% compared to 75% for 150 patients undergoing lobectomy and lesser procedures. Transfused patients had lower disease- free rates within 5 years than nontransfused patients (62% versus 76%, p = 0.0132). Survival advantage was also noted in nontransfused patients after deleting patients subjected to pneumonectomy. These results indicate that perioperative transfusion in patients with lung cancer undergoing resection accelerates the appearance of recurrent or metastatic cancer. This supports the findings of previous studies of breast and colon cancer that blood transfusion is detrimental to the patient with cancer.

This article has been cited by other articles:

				P. Thomas, P. Michelet, F. Barlesi, X. Thirion, C. Doddoli, R. Giudicelli, and P. Fuentes Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies Eur. Respir. J., March 1, 2007; 29(3): 565 - 570. [Abstract] [Full Text] [PDF]

				T. Le, G. Alshaikh, L. Hopkins, W. Faught, and M. F. K. Fung Prognostic Significance of Postoperative Morbidities in Patients With Advanced Epithelial Ovarian Cancer Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking Ann. Surg. Oncol., December 1, 2006; 13(12): 1711 - 1716. [Abstract] [Full Text] [PDF]

				W. Rzyman, R. Dziadziuszko, J. Skokowski, R. Wilimski, A. Raiter, A. Szymanowska, and J. Jassem The influence of blood transfusion on survival in operated non-small cell lung cancer patients J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 755 - 760. [Abstract] [Full Text] [PDF]

				M. Nosotti, P. Rebulla, D. Riccardi, A. Baisi, N. Bellaviti, L. Rosso, and L. Santambrogio Correlation Between Perioperative Blood Transfusion and Prognosis of Patients Subjected to Surgery for Stage I Lung Cancer Chest, July 1, 2003; 124(1): 102 - 107. [Abstract] [Full Text] [PDF]

				Y. Refaely, S. Sadetzki, A. Chetrit, D. A. Simansky, M. Paley, B. Modan, and A. Yellin The sequence of vessel interruption during lobectomy for non-small cell lung cancer: Is it indeed important? J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1313 - 1320. [Abstract] [Full Text] [PDF]

				Y. Ichinose, K. Genka, T. Koike, H. Kato, Y. Watanabe, T. Mori, S. Iioka, A. Sakuma, and M. Ohta Randomized Double-Blind Placebo-Controlled Trial of Bestatin in Patients With Resected Stage I Squamous-Cell Lung Carcinoma J Natl Cancer Inst, April 16, 2003; 95(8): 605 - 610. [Abstract] [Full Text] [PDF]

				M. Salsali The Effect of whole-Blood Transfusion on Survival of Patients with Breast Cancer: Why the Controversies? Vascular and Endovascular Surgery, October 1, 1993; 27(8): 567 - 577. [Abstract] [PDF]

				R. Bufalino and A. Morabito Combined Effect of Transfusion and Blood Groups on the Survival of Patients With Breast Cancer. A Clinical Study of 901 Patients {dagger} Vascular and Endovascular Surgery, November 1, 1988; 22(6): 402 - 412. [Abstract] [PDF]